Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 Precursors

Background: A major goal for the vaccine field is the elicitation of broadly neutralizing antibodies (bnAbs) against pathogens that exhibit extensive antigenic diversity. Methods: In this study, we designed a rigid divalent immunogen for high avidity binding to the bnAb, VRC01, which targets the CD4...

Полное описание

Библиографические подробности

Главные авторы:	Ryan Bailey, Kalista Kahoekapu, Albert To, Ludwig I. Mayerlen, Helmut Kae, Gabriel Manninen, Brien K. Haun, John M. Berestecky, Cecilia Shikuma, Axel T. Lehrer, Iain S. MacPherson
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2026-01-01
Серии:	Vaccines
Предметы:	HIV vaccine immune focusing germline targeting broadly neutralizing antibodies VRC01
Online-ссылка:	https://www.mdpi.com/2076-393X/14/1/58
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!